ES2073396T3 - Nuevos derivados ciclicos del acido antranilico y procedimiento para su preparacion. - Google Patents

Nuevos derivados ciclicos del acido antranilico y procedimiento para su preparacion.

Info

Publication number
ES2073396T3
ES2073396T3 ES88116141T ES88116141T ES2073396T3 ES 2073396 T3 ES2073396 T3 ES 2073396T3 ES 88116141 T ES88116141 T ES 88116141T ES 88116141 T ES88116141 T ES 88116141T ES 2073396 T3 ES2073396 T3 ES 2073396T3
Authority
ES
Spain
Prior art keywords
grupo
group
atom
carbon
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88116141T
Other languages
English (en)
Inventor
Eisuke Kojima
Shizuyoshi Fujimori
Katsuya Awano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63236295A external-priority patent/JPH01279867A/ja
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2073396T3 publication Critical patent/ES2073396T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DEL ACIDO ANTRANILICO CICLICOS DE LA FORMULA(I) EN DONDE R1, R2 Y R3 INDICAN INDEPENDIENTEMENTE CADA UNO UN ATOMO DE H, UN GRUPO ALQUILO INFERIOR TENIENDO 1 A 3 ATOMOS DE CARBONO, UN GRUPO ALCOXI TENIENDO DE 1 A 3 ATOMOS DE CARBONO, GRUPO AMINO, GRUPO NITRO, GRUPO HIDROXI, GRUPO SULFONAMIDA, GRUPO TRIFLUOROMETIL, GRUPO BENZOILMETILO EL CUAL PUEDE SER SUSTITUIDO, GRUPO ALCANOILAMINO TENIENDO DE 1 A 3 ATOMOS DE CARBONO, GRUPO BENZOILAMINO QUE PUEDE SER SUSTITUIDO, GRUPO ALQUILSULFONILAMINO TENIENDO DE 1 A 3 ATOMOS DE CARBONO O GRUPO FENILSULFONILAMINO QUE PUEDE SER SUSTITUIDO; R4 Y R5 INDICAN CADA UNO INDEPENDIENTEMENTE UN ATOMO DE H U OTROS GRUPOS; R6 INDICA UN ATOMO DE H U OTRA SUSTITUCION, X INDICA UN GRUPO METILENO U OTROS COMPUESTOS, SUS ACIDOS O SALES ALCALINOS DE ESTOS SON UTILES COMO AGENTES ANTIRREUMATICOS.
ES88116141T 1987-10-02 1988-09-29 Nuevos derivados ciclicos del acido antranilico y procedimiento para su preparacion. Expired - Lifetime ES2073396T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24960887 1987-10-02
JP879388 1988-01-19
JP63236295A JPH01279867A (ja) 1987-10-02 1988-09-22 新規環状アントラニル酸誘導体及びその製造法

Publications (1)

Publication Number Publication Date
ES2073396T3 true ES2073396T3 (es) 1995-08-16

Family

ID=27278180

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88116141T Expired - Lifetime ES2073396T3 (es) 1987-10-02 1988-09-29 Nuevos derivados ciclicos del acido antranilico y procedimiento para su preparacion.

Country Status (8)

Country Link
US (3) US4956372A (es)
EP (1) EP0310096B1 (es)
KR (1) KR960010350B1 (es)
CN (1) CN1032788A (es)
CA (1) CA1317294C (es)
DE (1) DE3853608T2 (es)
ES (1) ES2073396T3 (es)
HU (1) HU204802B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124325A (en) * 1989-06-13 1992-06-23 Kyorin Pharmaceutical Co., Ltd. Therapeutic agents of metabolic bone disease
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
EP0403980A1 (en) * 1989-06-19 1990-12-27 Kyorin Pharmaceutical Co., Ltd. Novel cyclic anthranilic acid carboxylic acid derivatives
JPH0327357A (ja) * 1989-06-26 1991-02-05 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸誘導体及びその製造法
US5248777A (en) * 1989-09-19 1993-09-28 Allergan, Inc. Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
JP3209568B2 (ja) * 1991-04-16 2001-09-17 杏林製薬株式会社 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
FR2714381B1 (fr) * 1993-12-29 1996-02-02 Pharmascience Lab Dérivés de la benzoxazine, leurs procédés d'obtention et leur utilisation en tant que médicaments .
US5696130A (en) 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
US6696459B1 (en) * 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
CZ292632B6 (cs) * 1995-10-05 2003-11-12 Kyoto Pharmaceutical Industries, Ltd. Indolinový, indolový nebo tetrahydrochinolinový derivát a farmaceutický přípravek s jeho obsahem
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
GB9724586D0 (en) * 1997-11-20 1998-01-21 Rhone Poulenc Agriculture New herbicides
FR2779144B1 (fr) * 1998-05-29 2000-06-30 Adir Nouveaux composes 8-amino-1,4-benzoxaziniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6180640B1 (en) 1998-06-25 2001-01-30 Sepracor, Inc. Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto
EP1541553B1 (en) * 2002-07-17 2010-06-02 Kyoto Pharmaceutical Industries, Ltd. Indoline compound and medicinal use thereof
CA2659299A1 (en) 2006-08-15 2008-02-21 Actelion Pharmaceuticals Ltd Azetidine compounds
WO2013076590A1 (en) * 2011-11-23 2013-05-30 Oxygen Healthcare Research Pvt. Ltd Benzothiazine compounds as h3 receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2733371A (en) * 1970-04-14 1972-10-12 A. H. Robins Company, Incorporated 5, 7-DISUBSTITUTED-l, 9-ALKYLENE-l, 4-BENZODIAZEPIN-2 ONES
US4843082A (en) * 1986-05-05 1989-06-27 E. R. Squibb & Sons, Inc. 1,2,3,4-tetrahydro-8-quinolinol derivatives and anti-allergic use thereof

Also Published As

Publication number Publication date
EP0310096B1 (en) 1995-04-19
EP0310096A3 (en) 1990-10-31
CA1317294C (en) 1993-05-04
US5147874A (en) 1992-09-15
HUT50459A (en) 1990-02-28
KR960010350B1 (ko) 1996-07-30
DE3853608D1 (de) 1995-05-24
CN1032788A (zh) 1989-05-10
DE3853608T2 (de) 1996-01-04
KR890006604A (ko) 1989-06-14
EP0310096A2 (en) 1989-04-05
US5281600A (en) 1994-01-25
US4956372A (en) 1990-09-11
HU204802B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
ES2072779T3 (es) Derivados aminoacidos anfoteros.
AR246275A1 (es) Composiciones de catalizador, procedimiento para la preparacion de polimeros de monoxido de carbono, y eteno y nuevo compuesto.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
AR247732A1 (es) Procedimiento para obtener amidas de acido piridin-2, 4- y -2, 5-dicarboxilico
DK0494978T3 (da) Heterocycliske forbindelser
ES2059391T3 (es) Derivados de dihidropiridina, su preparacion y su uso.
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
ES2260933T3 (es) Derivados del acido de tiazolina.
ES8405373A1 (es) Procedimiento para preparar nuevos derivados del benzo g 7-quinolina.
ES8600210A1 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ES8202015A1 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES2058177T3 (es) Nuevos derivados de alcanosulfonanilida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2145064T3 (es) Compuestos de penem sustituidos con metileno en posicion 6 y productos intermedios.
ES503837A0 (es) Procedimiento para la preparacion de 3,1-benzoxazin-2-onas
ES2040856T3 (es) Un procedimiento para preparar un compuesto de tiofeno.
ES2080859T3 (es) Alfa-(alquilciclohexiloxi)-beta-alcanoles y composiciones de perfume que contienen los mismos.
ES8502086A1 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES2061680T3 (es) Acidos y esteres azetidinilquinolonacarboxilicos.
ES2063156T3 (es) Nuevos derivados lisogangliosidos.
ES2028877T3 (es) Un procedimiento para preparar un compuesto heterociclico.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
DK314483D0 (da) Peenem-derivater, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler
AR240813A2 (es) N-fenilsulfonil-n'-pirimidinilureas, procedimiento para su preparacion, composiciones que las contienen e intermediarios para uso exclusivo en dicho procedimiento

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310096

Country of ref document: ES